SCHEMBL455729

SCHEMBL455729

Clc1ccc2nc(Br)c(I)n2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TNF P01375 1/20 0.39
DYRK1A Q13627 9/20 0.36
DYRK2 Q92630 9/20 0.36
DYRK1B Q9Y463 8/20 0.36
CDK5 Q00535 7/20 0.36
CDK5R1 Q15078 7/20 0.36
DYRK3 O43781 7/20 0.36
CCNA2 P20248 6/20 0.36
CDK2 P24941 6/20 0.36
CCNT1 O60563 4/20 0.36
CDK9 P50750 4/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MET P08581 1/20 0.33
NTRK1 P04629 1/20 0.32
AKT1 P31749 1/20 0.32
AKT2 P31751 1/20 0.32
PDE10A Q9Y233 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL460987 0.82 AKT1 (0.31) AKT1AKT2
SCHEMBL477062 0.78 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL18817029 0.78 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL3115930 0.73 NTRK1 (0.50) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL3108672 0.73 AKT1 (0.41) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL1745899 0.71 DYRK1A (0.41) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL4052890 0.70 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL1394183 0.70 AKT1 (0.40) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL3721378 0.69 ALDH1A1 (0.37) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A
SCHEMBL3728019 0.69 MKNK1 (0.39) KDM4EALDH1A1SMN1; SMN2TNFDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2825540-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2015-01-21 EP disclosed
WO-2013135612-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-09-19 WO disclosed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed